[Treatment possibilities of insulin resistance].
D000324:Adrenocorticotropic Hormone / Q000627:therapeutic use; D000328:Adult; D001645:Biguanides / Q000627:therapeutic use; D003920:Diabetes Mellitus / Q000188:drug therapy; D004342:Drug Hypersensitivity / Q000188:drug therapy*; D005260:Female; D005938:Glucocorticoids / Q000627:therapeutic use; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use; D007330:Insulin Antibodies; D007333:Insulin Resistance; D049528:Insulin, Long-Acting / Q000009:adverse effects; D008297:Male; D008875:Middle Aged; D010908:Pituitary Hormones, Anterior / Q000037:antagonists & inhibitors
D001645:Biguanides; D005938:Glucocorticoids; D007004:Hypoglycemic Agents; D007330:Insulin Antibodies; D049528:Insulin, Long-Acting; D010908:Pituitary Hormones, Anterior; D000324:Adrenocorticotropic Hormone
Behandlungsmöglichkeiten der Insulinresistenz.